70 results
DEFA14A
ELVN
Enliven Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:11pm
. successors Election of two are Class duly elected I directors and named qualified in or the until accompanying their earlier proxy death, statement
PRE 14A
ELVN
Enliven Therapeutics Inc
15 Apr 24
Preliminary proxy
4:05pm
are duly elected and qualified or until their earlier death, resignation or removal.
To ratify the appointment of Deloitte & Touche LLP as our … statement to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death
S-4/A
iakba1zgf6osbcd8
19 Dec 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
EX-10.2
t1pad 6j0w38q8cz6il8
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
S-4
3xwj2vm
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
425
7qwvwpit2nt o9y
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-2.1
vhequfnv zztdg43n
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-10.4
ixnbn 4gt
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm